Är överdragen crossboss insatt

Description:

Designed to quickly and safely deliver a guidewire via the true lumen or subintimal pathways, CrossBoss Catheter gives you total tillgång to coronary chronic total occlusions.

Product Details

  • Designed to quickly and safely deliver a guidewire via true lumen or subintimal pathways, CrossBoss gives you access to coronary chronic total occlusions.
  • Atraumatic, rounded tip reduces fara of perforation
  • Hydrophilic coated, multi-wire coiled shaft provides precise turn-for-turn response
  • Fast-Spin torque device allows rapid rotation of the catheter to facilitate crossing

Data

1. Technical Success = CrossBoss Stingray device facilitation of guidewire placement in true lumen distal to CTO,

Whitlow P, Lombardi W, Wyman M et al. Use of Novel Crossing and Re-Entry System, in Coronary Chronic Total Occlusions That Have Failed Standard Crossing Techniques. J Am Coll Cardiol Interv. ;

  • är överdragen crossboss insatt

    • What is a Crossboss Catheter?

    A Crossboss catheter is a specialized medical tool used to treat and navigate complicated coronary artery lesions, especially ones with side branches or bifurcations. Because of their complex anatomy and the possibility of consequences including restlessness and implant blood clots these lesions present serious obstacles to conventional interventional procedures.

    How does a Crossboss Catheter work?

    The Crossboss catheter employs advanced design features to overcome the challenges posed by complex Coronary Blockages….

    • High Flexibility: The catheter’s flexible tip allows it to maneuver through tortuous vessels and negotiate tight turns, reaching even the most difficult-to-access lesions.
    • Superior Trackability: The catheter’s trackability ensures accurate delivery of therapeutic devices, such as balloons and stents, to the target lesion.
    • Excellent Support: The catheter’s supportive shaft provides stability and control during the procedure, minimizing the risk of vessel injury and ensuring precise device deployment.

    What are the benefits of using a Crossboss Catheter?

    • Improved Procedural Success: The Cross-Boss catheter significantly en

      Use of the CrossBoss Catheter Studied for PCI of Chronic Total Occlusions

      October 31, —Findings from the CrossBoss First trial, which is evaluating the optimal initial strategy for crossing chronic total occlusions (CTOs) during percutaneous coronary intervention (PCI) procedures, were presented at TCT , the 29th annual Transcatheter Cardiovascular Therapeutics scientific symposium being held October 30 to November 2 in Denver, Colorado.

      As summarized in the TCT announcement, the study randomized patients undergoing coronary CTO intervention to upfront use of Boston Scientific's CrossBoss catheter (n = ) or wire escalation (n = ) at 11 centers in the United States. The CrossBoss First study was funded by Boston Scientific. Overall technical and procedural success rates were high and similar between the two groups.

      The primary efficacy endpoint of crossing time was similar in the two groups: 56 minutes (interquartile range, 33–93 min) in the CrossBoss group and 66 minutes (interquartile range, 36– min) in the wire escalation group (P = ). The incidence of procedural major adverse cardiovascular events was also similar (% vs %; P =